In addition to an increase in OPG, antagonizing sRANKL, it has been reported that the direct effect of RANKL on preosteoclasts is altered under hyperglycemia, inhibiting osteoclast fusion [28]. The gene discussed is TNFRSF11B; the disease is Hyperglycemia.